Evotec (EVTCY) News Today $3.58 -0.02 (-0.56%) As of 04/21/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Evotec AG: Strategic Cost Reduction and Just-Evotec Biologics Drive Long-Term Growth Amid Revenue ChallengesApril 17, 2025 | tipranks.comEQS-News: Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 resultsApril 17, 2025 | markets.businessinsider.comEvotec (OTCMKTS:EVTCY) Stock Price Crosses Below Fifty Day Moving Average - Time to Sell?Evotec (OTCMKTS:EVTCY) Share Price Passes Below 50 Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comEQS-AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsMarch 5, 2025 | markets.businessinsider.comEvotec SE: Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers SquibbMarch 4, 2025 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?Evotec (OTCMKTS:EVTCY) Share Price Crosses Above Fifty Day Moving Average - Should You Sell?March 2, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Pass Above 50 Day Moving Average - Here's What HappenedEvotec (OTCMKTS:EVTCY) Stock Crosses Above 50 Day Moving Average - Time to Sell?February 22, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Cross Above Fifty Day Moving Average - Here's What HappenedEvotec (OTCMKTS:EVTCY) Shares Cross Above 50-Day Moving Average - Should You Sell?February 5, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Pass Below Fifty Day Moving Average - Should You Sell?Evotec (OTCMKTS:EVTCY) Share Price Passes Below 50 Day Moving Average - Time to Sell?January 28, 2025 | marketbeat.comEvotec SE: Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung DiseasesJanuary 22, 2025 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyEvotec (OTCMKTS:EVTCY) Shares Cross Below 200 Day Moving Average - Here's What HappenedJanuary 18, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Passes Below 200-Day Moving Average - Time to Sell?Evotec (OTCMKTS:EVTCY) Shares Cross Below 200 Day Moving Average - Time to Sell?January 18, 2025 | marketbeat.comHalozyme withdraws $2.1 billion buyout offer for German drug developer EvotecNovember 25, 2024 | finance.yahoo.comEQS-News: Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market ConditionsNovember 6, 2024 | markets.businessinsider.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - What's Next?Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low - Here's WhyOctober 30, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 52-Week Low - Here's WhyEvotec (OTCMKTS:EVTCY) Sets New 12-Month Low - Here's WhyOctober 21, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Hits New 12-Month Low - Here's What HappenedEvotec (OTCMKTS:EVTCY) Hits New 1-Year Low - Time to Sell?October 14, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - Time to Sell?Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low - What's Next?October 8, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Crosses Below 50 Day Moving Average of $3.70Evotec (OTCMKTS:EVTCY) Shares Cross Below 50 Day Moving Average of $3.70October 1, 2024 | marketbeat.comEvotec SE: Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD Toulouse, FranceSeptember 20, 2024 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.27Evotec (OTCMKTS:EVTCY) Sets New 1-Year Low at $3.27September 11, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.66Evotec (OTCMKTS:EVTCY) Sets New 52-Week Low at $3.66August 30, 2024 | marketbeat.comAnalysts Have Been Trimming Their Evotec SE (ETR:EVT) Price Target After Its Latest ReportAugust 17, 2024 | uk.finance.yahoo.comEvotec SE (NASDAQ:EVO) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comEvotec SE: Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers SquibbAugust 8, 2024 | finanznachrichten.deEQEvotec SE Appoints Dr Christian Wojczewski as Chief Executive OfficerApril 24, 2024 | finance.yahoo.comEQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive OfficerApril 23, 2024 | markets.businessinsider.comEvotec SE: Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The ClinicMarch 6, 2024 | finanznachrichten.deEvotec SE: Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD TherapiesJanuary 10, 2024 | finanznachrichten.deEvotec, Owkin Anounce A.I.-Powered Collaboration In Oncology, Immunology, And InflammationJanuary 4, 2024 | markets.businessinsider.comEvotec SE (NASDAQ:EVO) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comEQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate updateNovember 8, 2023 | markets.businessinsider.com65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in SingaporeOctober 5, 2023 | finance.yahoo.comEvotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D EconomySeptember 27, 2023 | finance.yahoo.comEvotec SE (EVO) Stock Historical Prices & Data - Yahoo FinanceSeptember 21, 2023 | finance.yahoo.comIs There Now An Opportunity In Evotec SE (ETR:EVT)?May 30, 2023 | finance.yahoo.comEvotec SE (ETR:EVT) Shares Could Be 37% Below Their Intrinsic Value EstimateMay 14, 2023 | finance.yahoo.comEvotec SE: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023May 13, 2023 | finanznachrichten.deEvotec SE ADR (EVO) Earnings Dates & ReportsMay 12, 2023 | investing.comEvotec SE ADR (EVO)May 10, 2023 | investing.comEvotec SE: Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial ManufacturingMay 9, 2023 | finanznachrichten.deEvotec SE Provides Update on Cyber AttackApril 10, 2023 | finance.yahoo.comEvotec SE: Evotec Receives € 150 m Loan from European Investment BankFebruary 10, 2023 | finanznachrichten.deEQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionJanuary 31, 2023 | markets.businessinsider.comWith 47% ownership, Evotec SE (ETR:EVT) has piqued the interest of institutional investorsDecember 22, 2022 | ca.finance.yahoo.comEvotec SE: Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers SquibbDecember 17, 2022 | finanznachrichten.deEvotec SE: Just - Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies ProgramSeptember 21, 2022 | finanznachrichten.deEvotec: US Unit Gets $49.9 Mln Antibodies Contract From U.S. Department Of DefenseSeptember 20, 2022 | markets.businessinsider.comEvotec SE: Evotec Initiates Ground-Breaking for New Biologics Facility J.POD Toulouse, FranceSeptember 17, 2022 | finanznachrichten.deEvotec SE's (EVOTF) CEO Dr. Werner Lanthaler on Q2 2022 Results - Earnings Call TranscriptAugust 13, 2022 | seekingalpha.com Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address EVTCY Media Mentions By Week EVTCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVTCY News Sentiment▼1.210.71▲Average Medical News Sentiment EVTCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVTCY Articles This Week▼20▲EVTCY Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RYTM News Today PCVX News Today ACLX News Today PTCT News Today RARE News Today OGN News Today RNA News Today MOR News Today AKRO News Today MRUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EVTCY) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVTCY Stock Free EVTCY Stock Alerts